These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6698219)

  • 1. Salivary progesterone as an index of the luteal function.
    Zorn JR; McDonough PG; Nessman C; Janssens Y; Cedard L
    Fertil Steril; 1984 Feb; 41(2):248-53. PubMed ID: 6698219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of progesterone in saliva: application to the assessment of ovarian function.
    Walker RF; Read GF; Riad-Fahmy D
    Clin Chem; 1979 Dec; 25(12):2030-3. PubMed ID: 509701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between endometrial biopsy and serum progesterone level in prediction of corpus luteum function.
    El-hefnawi N; Abou-gabal A; El-etriby A; Maged M; Wafa G; Ragab I
    Popul Sci; 1987; 7():139-51. PubMed ID: 12315537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum progesterone and endometrial biopsy for confirmation of ovulation and evaluation of luteal function.
    Shepard MK; Senturia YD
    Fertil Steril; 1977 May; 28(5):541-8. PubMed ID: 856637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of progesterone in saliva: a simplified technique using 125I-radioligand.
    Tho SP; Scholer J; Phung BV; Harp RJ; McDonough PG
    Fertil Steril; 1985 Mar; 43(3):410-6. PubMed ID: 3979579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE; Kettel LM; Yen SS
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
    Li TC; Dockery P; Thomas P; Rogers AW; Lenton EA; Cooke ID
    Fertil Steril; 1988 Nov; 50(5):732-42. PubMed ID: 3181485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normative study of age variation in salivary progesterone profiles.
    Lipson SF; Ellison PT
    J Biosoc Sci; 1992 Apr; 24(2):233-44. PubMed ID: 1583036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular growth and corpus luteum function in women with unexplained infertility, monitored by ultrasonography and measurement of daily salivary progesterone.
    Finn MM; Gosling JP; Tallon DF; Joyce LA; Meehan FP; Fottrell PF
    Gynecol Endocrinol; 1989 Dec; 3(4):297-308. PubMed ID: 2626978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why does RU486 fail to prevent implantation despite success in inducing menstruation?
    Li TC; Lenton EA; Dockery P; Rogers AW; Cooke ID
    Contraception; 1988 Oct; 38(4):401-6. PubMed ID: 3208514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial dating correlated with progesterone levels.
    Nadji P; Reyniak JV; Sedlis A; Szarowski DH; Bartosik D
    Obstet Gynecol; 1975 Feb; 45(2):193-4. PubMed ID: 1118093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone and estradiol in the saliva and plasma during the menstrual cycle.
    Choe JK; Khan-Dawood FS; Dawood MY
    Am J Obstet Gynecol; 1983 Nov; 147(5):557-62. PubMed ID: 6638098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between daily salivary progesterone profile and endometrial development in the luteal phase of fertile and infertile women.
    Li TC; Lenton EA; Dockery P; Rogers AW; Cooke ID
    Br J Obstet Gynaecol; 1989 Apr; 96(4):445-53. PubMed ID: 2751958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.